Most Read Articles
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
12 Dec 2016

Associate Professor Ng Lee Ching, Director of the Environmental Health Institute (EHI) at the National Environment Agency (NEA), Singapore, speaks about the role of primary care physicians and government agencies in preventing dengue epidemics.

22 Aug 2018
In patients with atrial fibrillation (AF) naïve to oral anticoagulants (OACs), standard-dose nonvitamin K antagonist OACs (NOACs) provides better survival benefits than warfarin, a recent meta-analysis has shown.
Stephen Padilla, 31 Aug 2018
Treatment with rivaroxaban results in less recurrent venous thromboembolism (VTE) in frail patients with VTE, with similar good bleeding outcomes, compared with warfarin, reports a study.

Anaemia linked to out-of-range INR in patients taking warfarin

20 Oct 2019

Younger, female patients prescribed warfarin are more likely to present with in-clinic anaemia, and these patients are at risk for out-of-range international normalized ratio (INR), suggests a recent study.

“Pharmacists practicing in anticoagulation clinics can incorporate this information into patient care practice in efforts to maintain optimal management,” the authors suggested.

This retrospective chart review sought to explore the relationship between in-clinic anaemia and the control of INR within an anticoagulation clinic. A random sample of patients seen in an academic medical centre pharmacy-managed anticoagulation clinic was enrolled in this study.

The authors used the Hemochron Signature Elite machine to monitor point-of-care INR. They also carried out statistical analyses with the use of the web-based platform STATA MP (https://www.stata.com/statamp/).

In-clinic anaemia was defined as haematocrit <32 percent.

A total of 300 patients were included in the analysis, of whom 45 (15 percent) had in-clinic anaemia. Patients with in-clinic anaemia were more likely to be younger (p<0.05), female (p<0.05), and have a diagnosis of sickle cell disease or anaemia (p<0.05).

Of note, patients diagnosed with in-clinic anaemia were shown to be at increased risk of having out-of-range INR (odds ratio, 0.52, 95 percent CI, 0.27–0.98) in the unadjusted logistic regression model. In addition, no significance was seen in the adjusted regression model.

“Many factors influence INR,” according to the authors. “[H]owever, few studies have examined the impact of anaemia in warfarin patients.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
12 Dec 2016

Associate Professor Ng Lee Ching, Director of the Environmental Health Institute (EHI) at the National Environment Agency (NEA), Singapore, speaks about the role of primary care physicians and government agencies in preventing dengue epidemics.

22 Aug 2018
In patients with atrial fibrillation (AF) naïve to oral anticoagulants (OACs), standard-dose nonvitamin K antagonist OACs (NOACs) provides better survival benefits than warfarin, a recent meta-analysis has shown.
Stephen Padilla, 31 Aug 2018
Treatment with rivaroxaban results in less recurrent venous thromboembolism (VTE) in frail patients with VTE, with similar good bleeding outcomes, compared with warfarin, reports a study.